Formulation and Development of Gastroretentive Hydrogels of Glipizide

Authors

  • Vasanth Samaga Department of Pharmacy, Sambalpur University, Sambalpur, India
  • S.B. Puranik Department of Pharmacy, Bangalore, Karnataka, India

DOI:

https://doi.org/10.37591/rrjodfdp.v4i1.347

Abstract

The aim of the present study was to develop a pH sensitive gastroretentive drug delivery system for an antidiabetic drug glipizide, based on gas formation technique using 32-factorial design, in order to prolong the gastric residence time and increase the overall bioavailability of the dosage form, since the absorption is erratic in diabetic patients. The system consists of the drug, glycol chitosan (5% w/w) and aqueous PVA solution (10% w/w) which were mixed together and pH was adjusted to 4.5–5.0. Then the crosslinking agent (10% aqueous glyoxal) was added, followed by sodium bicarbonate which acts as foaming agent. In acidic environment, superporous hydrogels showed higher swelling ratio because of the cationization of amine groups. The presence of PVA and increased levels of crosslinker significantly improved the mechanical strength of the superporous hydrogels. The drug release studies showed that sustained release of drug could be achieved with high crosslink density and higher amount of PVA.

 

Keywords: Hydrogels, pH sensitive, gastroretentive, glipizide, factorial design

Cite this Article

Vasanth Samaga, Puranik SB. Formulation and Development of Gastroretentive Hydrogels of Glipizide. Research & Reviews: A Journal of Drug Formulation, Development and Production. 2017; 4(1): 1–7p.

Downloads

Published

2019-02-28

Issue

Vol. 4 No. 1 (2017)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.